In August CTS begins source plasma testing as a new line of business to one of the largest plasma fractionators in the industry.
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...